Easydiet S.R.L.
- Address
- Strada Mr. Sontu Gheorghe Nr 3, 011447 Bucharest, Romania
Easydiet S.R.L. - Metabolic Disease Research Center
Easydiet S.R.L. is a specialized clinical research center focused on advancing therapeutic strategies for metabolic disorders, with particular expertise in type 2 diabetes and associated conditions. The center plays a crucial role in evaluating novel pharmacological interventions aimed at improving glycemic control and addressing cardiometabolic complications in patients with metabolic syndrome.
- Type 2 diabetes management and glucose-lowering therapies, including next-generation GLP-1 receptor agonists
- Cardiovascular risk reduction in patients with diabetes, obesity, and overweight
- Comparative effectiveness studies of emerging oral and injectable diabetes treatments
The research center demonstrates significant experience in conducting comparative trials that evaluate treatment switching strategies and assess the efficacy of innovative compounds such as tirzepatide and orforglipron. Their work contributes to understanding how newer therapies compare to established standards of care like insulin glargine and dulaglutide, with emphasis on both metabolic outcomes and cardiovascular safety endpoints in high-risk patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eli Lilly Cork Limited1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Easydiet S.R.L.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes | Eli Lilly Cork Limited | Phase III | Not Yet Recruiting | Jun 2023 | Jul 2024 |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Canagliflozin | 2 | Unknown | 2023-06-07 | 2023-08-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.